Gyrolab® generic PK assay: Determination of human IgG in preclinical Matrices
Challenges affecting productivity and meeting tight timelines in preclinical PK studies include the need to study multiple candidates and efficacy and safety parameters in at least two experimental animal models, limited sample volumes, assay development and selection of reagents.
Daniel Forsström, scientist at Gyros Protein Technologies, will in this webinar presents data using a high performance generic PK assay kit optimized for use with Gyrolab automated nanoliter-scale immunoassay systems. The kit accurately and robustly quantifies human IgG1, IgG2, or IgG4 titer over a broad, three-log range in a number of matrices. Results are generated in 70 minutes.